Articles |

Multimodality Therapy for Esophageal Cancer FREE TO VIEW

Arlene A. Forastiere; Richard F. Heitmiller; Lawrence Kleinberg
Author and Funding Information

From the Departments of Oncology and Surgery, Johns Hopkins University School of Medicine, Baltimore

1997 by the American College of Chest Physicians

Chest. 1997;112(4_Supplement):195S-200S. doi:10.1378/chest.112.4_Supplement.195S
Text Size: A A A
Published online


Over the past decade and a half, several strategies have been developed to improve the survival of patients with esophageal cancer. Two strategies employ either neoadjuvant chemotherapy or chemoradiotherapy followed by surgery to improve local-regional control and decrease the incidence of distant metastases. A third strategy uses nonsurgical therapy as definitive treatment for patients without metastatic disease. Single-institution pilot trials and randomized comparative trials have been conducted evaluating each approach. The rationale for these trials, results, and current recommendations are presented.




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543